7wireVentures Portfolio Company Ayogo Completes $7.5M Series B Financing led by Baxter and MEDTEQ
Financing to accelerate growth of Ayogo’s healthcare engagement platform.
RecoveryOne Makes Telehealth Solution Available at No Cost During COVID-19 Pandemic
7wire Ventures Portfolio company will provide a digital recovery platform for musculoskeletal conditions to employers and health plans for free.
FDA OKs digital health tools for use during pandemic
The FDA gave Livongo an emergency use authorization to allow its blood glucose monitors to be used in hospitals, and has loosened requirements around the use of digital tools for mental health.
NOCD’s therapy app sees sessions double during pandemic
7wireVentures portfolio company NOCD has seen the number of people using its platform double since the Covid-19 pandemic started.
Survey: More than half of patients concerned that COVID-19 will affect medication regimen
A user survey done by Medisafe shows people with chronic conditions are even more concerned about their health and how they will manage it in isolation during the coronavirus.
Susan Rawlings Molina Joins RecoveryOne Board of Directors
Susan Rawlings Molina Joins RecoveryOne Board of Directors.
OCD Patients Flock to Chicago Startup’s Online Therapy App Amid Coronavirus
7wireVentures portfolio company NOCD sees big increase during Coronavirus.
The Coronavirus Pandemic May Be Causing an Anxiety Pandemic
7wireVentures portfolio company NOCD shares how the new environment impacts people with OCD.
7wireVentures Presents: Top of the Ladder Featuring ConsejoSano Founder and CEO Abner Mason
7wire had the pleasure of sitting down with our portfolio company executive, Abner Mason, Founder and CEO of ConsejoSano. During our discussion, we learned about his childhood dreams and discoveries as a CEO.
Some with OCD, other anxiety disorders are struggling amid the coronavirus epidemic. ‘It’s tripping the wire for many different people.’
7wireVentures portfolio company NOCD provides additional relief through virtual treatment for many triggered by COVID-19.